Literature DB >> 15246279

Molecular evidence of inefficient transduction of proliferating human B lymphocytes by VSV-pseudotyped HIV-1-derived lentivectors.

M Serafini1, L Naldini, M Introna.   

Abstract

Lentiviral vectors are attractive tools to transduce dividing and nondividing cells. Human tonsillar B lymphocytes have been purified and induced to proliferate by the addition of anti-CD40 + IL-4 or anti-CD40 + anti-micro signals and transduced at high MOI with a VSV pseudotyped lentivector carrying the eGFP gene under the control of the PGK promoter. Parallel cultures of PHA-stimulated T lymphocytes containing a comparable amount of cycling cells during the infection reached over 70% eGFP transduction. By contrast, only less than 3% B lymphocytes became eGFP positive after 7 days from transduction. Molecular analysis of the viral life cycle shows that cytoplasmic retrotranscribed cDNA and nuclear 2LTR circles are detectable at lower levels and for a shorter period of time in proliferating B cells with respect to proliferating T lymphocytes. Moreover, FACS-sorted eGFP-positive and negative B cell populations were both positive for the presence of retrotranscribed cDNA and 2LTR circles nuclear forms. By contrast, nested Alu-LTR PCR allowed us to detect an integrated provirus in FACS-sorted eGFP-positive cells only. Together with the demonstration that infection in saturation conditions led to an increase in the percentage of transduced cells (reaching 9%), these findings suggest that in proliferating B lymphocytes, lentiviral transduction is an inefficient process blocked at the early steps of the viral life cycle possibly involving partially saturable restriction factors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15246279     DOI: 10.1016/j.virol.2004.04.038

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  16 in total

Review 1.  Advances in the field of lentivector-based transduction of T and B lymphocytes for gene therapy.

Authors:  Cecilia Frecha; Camille Lévy; François-Loïc Cosset; Els Verhoeyen
Journal:  Mol Ther       Date:  2010-08-24       Impact factor: 11.454

2.  A Lentiviral Vector Allowing Physiologically Regulated Membrane-anchored and Secreted Antibody Expression Depending on B-cell Maturation Status.

Authors:  Floriane Fusil; Sara Calattini; Fouzia Amirache; Jimmy Mancip; Caroline Costa; Justin B Robbins; Florian Douam; Dimitri Lavillette; Mansun Law; Thierry Defrance; Els Verhoeyen; François-Loïc Cosset
Journal:  Mol Ther       Date:  2015-08-18       Impact factor: 11.454

3.  Lentiviral vectors displaying modified measles virus gp overcome pre-existing immunity in in vivo-like transduction of human T and B cells.

Authors:  Camille Lévy; Fouzia Amirache; Caroline Costa; Cecilia Frecha; Claude P Muller; Hasan Kweder; Robin Buckland; François-Loïc Cosset; Els Verhoeyen
Journal:  Mol Ther       Date:  2012-05-22       Impact factor: 11.454

4.  Measles virus glycoprotein-pseudotyped lentiviral vector-mediated gene transfer into quiescent lymphocytes requires binding to both SLAM and CD46 entry receptors.

Authors:  Cecilia Frecha; Camille Lévy; Caroline Costa; Didier Nègre; Fouzia Amirache; Robin Buckland; Steven J Russell; François-Loïc Cosset; Els Verhoeyen
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

5.  High Efficiency Ex Vivo Gene Transfer to Primary Murine B Cells Using Plasmid or Viral Vectors.

Authors:  Babak Moghimi; Irene Zolotukhin; Brandon K Sack; Roland W Herzog; Ou Cao
Journal:  J Genet Syndr Gene Ther       Date:  2011-03-15

6.  In vivo stable transduction of humanized liver tissue in chimeric mice via high-capacity adenovirus-lentivirus hybrid vector.

Authors:  Shuji Kubo; Miho Kataoka; Chise Tateno; Katsutoshi Yoshizato; Yoshiko Kawasaki; Takahiro Kimura; Emmanuelle Faure-Kumar; Donna J Palmer; Philip Ng; Haruki Okamura; Noriyuki Kasahara
Journal:  Hum Gene Ther       Date:  2010-01       Impact factor: 5.695

Review 7.  The inside out of lentiviral vectors.

Authors:  Stéphanie Durand; Andrea Cimarelli
Journal:  Viruses       Date:  2011-02-14       Impact factor: 5.818

8.  Engineering fusogenic molecules to achieve targeted transduction of enveloped lentiviral vectors.

Authors:  Yuning Lei; Kye-Il Joo; Pin Wang
Journal:  J Biol Eng       Date:  2009-06-02       Impact factor: 4.355

9.  In vitro transfection of bone marrow-derived dendritic cells with TATp-liposomes.

Authors:  Juan Sebastián Pappalardo; Cecilia A Langellotti; Sebastián Di Giacomo; Valeria Olivera; Valeria Quattrocchi; Patricia I Zamorano; William C Hartner; Tatyana S Levchenko; Vladimir P Torchilin
Journal:  Int J Nanomedicine       Date:  2014-02-13

10.  CD19 and CD20 targeted vectors induce minimal activation of resting B lymphocytes.

Authors:  Sabrina Kneissl; Qi Zhou; Michael Schwenkert; François-Loic Cosset; Els Verhoeyen; Christian J Buchholz
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.